Cargando…
mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
Thrombotic thrombocytopenic purpura (TTP) is primarily caused by deficiency of ADAMTS13 within the blood stream due to either genetic defects or presence of inhibitory autoantibodies. Preclinical and clinical studies suggest that enzyme replacement therapy with recombinant human ADAMTS13 protein (rh...
Autores principales: | Liu-Chen, Susan, Connolly, Brendan, Cheng, Lei, Subramanian, Romesh R., Han, Zhaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959889/ https://www.ncbi.nlm.nih.gov/pubmed/29777164 http://dx.doi.org/10.1038/s41598-018-26298-4 |
Ejemplares similares
-
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
por: Connolly, Brendan, et al.
Publicado: (2018) -
Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13
por: Jiang, Yizhi, et al.
Publicado: (2020) -
Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
por: Asrani, Kirtika H., et al.
Publicado: (2018) -
Increased expression of ADAMTS13 mRNA correlates with ischemic cerebrovascular disease in systemic lupus erythematosus patients
por: López De Padilla, Consuelo M, et al.
Publicado: (2013) -
Expression of ADAMTS-1 mRNA in myocardium of viral heart disease mice and its clinical significance
por: Li, Hongmei, et al.
Publicado: (2019)